R
Summary of public USPTO data
- Owner
- Regeneron Pharmaceuticals, Inc.
- Status
- Live/Registered
- Serial number
- 99742150
- Registration number
- 8523019
- Filing date
- 2026-04-02
- Registration date
- 2026-10-27
- International classes
- 40, 42, 44
Goods and services
Class 40
- Production of cell lines for use in the manufacture of biopharmaceuticals
- Protein fabrication, production, and manufacture for others
Class 42
- Research and development of pharmaceutical products
- Genetic engineering services utilizing a collection of genetic technologies for the rapid production of human antibodies
- Genetic engineering services, namely, deletion and modification of genes for others, and production of genetically modified animals
- Genetic research
- Genetic engineering services for genes, cells, and animals using non-human embryonic stem cells (ES) and non-human embryo manipulation technology for rapid development of genetically modified non-human animals
- Genetic engineering services, namely, the production of genetically-engineered antibodies for others
- Genetic engineering services, namely, scientific laboratory services in the nature of the production of genetic sequences for others for scientific research and pharmaceutical research and development purposes
- Scientific research in the field of genetics, genetic engineering, genetic sequencing, disease modeling, pharmacogenomics, and precision medicine
- Providing medical and scientific research information in the fields of pharmaceuticals and genetics
Class 44
- Medical information
- medical assistance services